Harvard Bioscience (HBIO) Treasury Shares (2010 - 2026)

Harvard Bioscience (HBIO) has 12 years of Treasury Shares data on file, last reported at $10.7 million in Q1 2021.

• On a quarterly basis, Treasury Shares changed 0.0% year-over-year to $10.7 million in Q1 2021; TTM through Mar 2021 was $10.7 million, a 0.0% change from a year earlier, with the FY2020 full-year figure at $10.7 million, changed 0.0% from the prior year.
• Treasury Shares for Q1 2021 stood at $10.7 million, roughly flat from $10.7 million in the prior quarter.
• Over the last five years, Treasury Shares for HBIO reached as high as $2.1 million in Q1 2023 and fell as low as $50000.0 in Q1 2026.
• Historically, Treasury Shares has averaged $1.2 million across 5 years, with a median of $1.5 million in 2022.
• On a YoY basis, Treasury Shares climbed as much as 0.0% in 2017 and fell as far as 0.0% in 2017.
• Year by year, Treasury Shares stood at $10.7 million in 2017, then changed by 0.0% to $10.7 million in 2018, then changed by 0.0% to $10.7 million in 2019, then changed by 0.0% to $10.7 million in 2020, then changed by 0.0% to $10.7 million in 2021.
• Per Business Quant data, the three most recent Treasury Shares figures were $10.7 million in Q1 2021, $10.7 million in Q4 2020, and $10.7 million in Q3 2020.